Reduced Folate Carrier: an Entry Receptor for a Novel Feline Leukemia Virus Variant

Feline leukemia virus (FeLV) is a member of the genus Gammaretrovirus , which causes malignant diseases in cats. The most prevalent FeLV among cats is FeLV subgroup A (FeLV-A), and specific binding of FeLV-A Env to its viral receptor, thiamine transporter feTHTR1, is the first step of infection. In...

Full description

Saved in:
Bibliographic Details
Published inJournal of virology Vol. 93; no. 13
Main Authors Miyake, Ariko, Kawasaki, Junna, Ngo, Ha, Makundi, Isaac, Muto, Yutaro, Khan, Arshad H., Smith, Desmond J., Nishigaki, Kazuo
Format Journal Article
LanguageEnglish
Published United States American Society for Microbiology 01.07.2019
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Feline leukemia virus (FeLV) is a member of the genus Gammaretrovirus , which causes malignant diseases in cats. The most prevalent FeLV among cats is FeLV subgroup A (FeLV-A), and specific binding of FeLV-A Env to its viral receptor, thiamine transporter feTHTR1, is the first step of infection. In infected cats, novel variants of FeLV with altered receptor specificity for viral entry have emerged by mutation or recombination of the env gene. A novel FeLV variant arose from a subtle mutation of FeLV-A Env, which altered the specific interaction of the virus with its receptor. RFC, a folate transporter, is a potential receptor for the novel FeLV variant. The perturbation of specific retrovirus-receptor interactions under selective pressure by the host results in the emergence of novel viruses. Feline leukemia virus (FeLV) is horizontally transmitted among cats and causes a variety of hematopoietic disorders. Five subgroups of FeLV, A to D and T, each with distinct receptor usages, have been described. Recently, we identified a new FeLV Env (TG35-2) gene from a pseudotyped virus that does not belong to any known subgroup. FeLV-A is the primary virus from which other subgroups have emerged via mutation or recombination of the subgroup A env gene. Retrovirus entry into cells is mediated by the interaction of envelope protein (Env) with specific cell surface receptors. Here, phenotypic screening of a human/hamster radiation hybrid panel identified SLC19A1, a feline reduced folate carrier (RFC) and potential receptor for TG35-2-phenotypic virus. RFC is a multipass transmembrane protein. Feline and human RFC cDNAs conferred susceptibility to TG35-2-pseudotyped virus when introduced into nonpermissive cells but did not render these cells permissive to other FeLV subgroups or feline endogenous retrovirus. Moreover, human cells with genomic deletion of RFC were nonpermissive for TG35-2-pseudotyped virus infection, but the introduction of feline and human cDNAs rendered them permissive. Mutation analysis of FeLV Env demonstrated that amino acid substitutions within variable region A altered the specificity of the Env-receptor interaction. We isolated and reconstructed the full-length infectious TG35-2-phenotypic provirus from a naturally FeLV-infected cat, from which the FeLV Env (TG35-2) gene was previously isolated, and compared the replication of the virus in hematopoietic cell lines with that of FeLV-A 61E by measuring the viral RNA copy numbers. These results provide a tool for further investigation of FeLV infectious disease. IMPORTANCE Feline leukemia virus (FeLV) is a member of the genus Gammaretrovirus , which causes malignant diseases in cats. The most prevalent FeLV among cats is FeLV subgroup A (FeLV-A), and specific binding of FeLV-A Env to its viral receptor, thiamine transporter feTHTR1, is the first step of infection. In infected cats, novel variants of FeLV with altered receptor specificity for viral entry have emerged by mutation or recombination of the env gene. A novel FeLV variant arose from a subtle mutation of FeLV-A Env, which altered the specific interaction of the virus with its receptor. RFC, a folate transporter, is a potential receptor for the novel FeLV variant. The perturbation of specific retrovirus-receptor interactions under selective pressure by the host results in the emergence of novel viruses.
AbstractList Feline leukemia virus (FeLV) is horizontally transmitted among cats and causes a variety of hematopoietic disorders. Five subgroups of FeLV, A to D and T, each with distinct receptor usages, have been described. Recently, we identified a new FeLV Env (TG35-2) gene from a pseudotyped virus that does not belong to any known subgroup. FeLV-A is the primary virus from which other subgroups have emerged via mutation or recombination of the subgroup A gene. Retrovirus entry into cells is mediated by the interaction of envelope protein (Env) with specific cell surface receptors. Here, phenotypic screening of a human/hamster radiation hybrid panel identified SLC19A1, a feline reduced folate carrier (RFC) and potential receptor for TG35-2-phenotypic virus. RFC is a multipass transmembrane protein. Feline and human RFC cDNAs conferred susceptibility to TG35-2-pseudotyped virus when introduced into nonpermissive cells but did not render these cells permissive to other FeLV subgroups or feline endogenous retrovirus. Moreover, human cells with genomic deletion of RFC were nonpermissive for TG35-2-pseudotyped virus infection, but the introduction of feline and human cDNAs rendered them permissive. Mutation analysis of FeLV Env demonstrated that amino acid substitutions within variable region A altered the specificity of the Env-receptor interaction. We isolated and reconstructed the full-length infectious TG35-2-phenotypic provirus from a naturally FeLV-infected cat, from which the FeLV Env (TG35-2) gene was previously isolated, and compared the replication of the virus in hematopoietic cell lines with that of FeLV-A 61E by measuring the viral RNA copy numbers. These results provide a tool for further investigation of FeLV infectious disease. Feline leukemia virus (FeLV) is a member of the genus , which causes malignant diseases in cats. The most prevalent FeLV among cats is FeLV subgroup A (FeLV-A), and specific binding of FeLV-A Env to its viral receptor, thiamine transporter feTHTR1, is the first step of infection. In infected cats, novel variants of FeLV with altered receptor specificity for viral entry have emerged by mutation or recombination of the gene. A novel FeLV variant arose from a subtle mutation of FeLV-A Env, which altered the specific interaction of the virus with its receptor. RFC, a folate transporter, is a potential receptor for the novel FeLV variant. The perturbation of specific retrovirus-receptor interactions under selective pressure by the host results in the emergence of novel viruses.
Feline leukemia virus (FeLV) is a member of the genus Gammaretrovirus , which causes malignant diseases in cats. The most prevalent FeLV among cats is FeLV subgroup A (FeLV-A), and specific binding of FeLV-A Env to its viral receptor, thiamine transporter feTHTR1, is the first step of infection. In infected cats, novel variants of FeLV with altered receptor specificity for viral entry have emerged by mutation or recombination of the env gene. A novel FeLV variant arose from a subtle mutation of FeLV-A Env, which altered the specific interaction of the virus with its receptor. RFC, a folate transporter, is a potential receptor for the novel FeLV variant. The perturbation of specific retrovirus-receptor interactions under selective pressure by the host results in the emergence of novel viruses. Feline leukemia virus (FeLV) is horizontally transmitted among cats and causes a variety of hematopoietic disorders. Five subgroups of FeLV, A to D and T, each with distinct receptor usages, have been described. Recently, we identified a new FeLV Env (TG35-2) gene from a pseudotyped virus that does not belong to any known subgroup. FeLV-A is the primary virus from which other subgroups have emerged via mutation or recombination of the subgroup A env gene. Retrovirus entry into cells is mediated by the interaction of envelope protein (Env) with specific cell surface receptors. Here, phenotypic screening of a human/hamster radiation hybrid panel identified SLC19A1, a feline reduced folate carrier (RFC) and potential receptor for TG35-2-phenotypic virus. RFC is a multipass transmembrane protein. Feline and human RFC cDNAs conferred susceptibility to TG35-2-pseudotyped virus when introduced into nonpermissive cells but did not render these cells permissive to other FeLV subgroups or feline endogenous retrovirus. Moreover, human cells with genomic deletion of RFC were nonpermissive for TG35-2-pseudotyped virus infection, but the introduction of feline and human cDNAs rendered them permissive. Mutation analysis of FeLV Env demonstrated that amino acid substitutions within variable region A altered the specificity of the Env-receptor interaction. We isolated and reconstructed the full-length infectious TG35-2-phenotypic provirus from a naturally FeLV-infected cat, from which the FeLV Env (TG35-2) gene was previously isolated, and compared the replication of the virus in hematopoietic cell lines with that of FeLV-A 61E by measuring the viral RNA copy numbers. These results provide a tool for further investigation of FeLV infectious disease. IMPORTANCE Feline leukemia virus (FeLV) is a member of the genus Gammaretrovirus , which causes malignant diseases in cats. The most prevalent FeLV among cats is FeLV subgroup A (FeLV-A), and specific binding of FeLV-A Env to its viral receptor, thiamine transporter feTHTR1, is the first step of infection. In infected cats, novel variants of FeLV with altered receptor specificity for viral entry have emerged by mutation or recombination of the env gene. A novel FeLV variant arose from a subtle mutation of FeLV-A Env, which altered the specific interaction of the virus with its receptor. RFC, a folate transporter, is a potential receptor for the novel FeLV variant. The perturbation of specific retrovirus-receptor interactions under selective pressure by the host results in the emergence of novel viruses.
Feline leukemia virus (FeLV) is horizontally transmitted among cats and causes a variety of hematopoietic disorders. Five subgroups of FeLV, A to D and T, each with distinct receptor usages, have been described. Recently, we identified a new FeLV Env (TG35-2) gene from a pseudotyped virus that does not belong to any known subgroup. FeLV-A is the primary virus from which other subgroups have emerged via mutation or recombination of the subgroup A env gene. Retrovirus entry into cells is mediated by the interaction of envelope protein (Env) with specific cell surface receptors. Here, phenotypic screening of a human/hamster radiation hybrid panel identified SLC19A1, a feline reduced folate carrier (RFC) and potential receptor for TG35-2-phenotypic virus. RFC is a multipass transmembrane protein. Feline and human RFC cDNAs conferred susceptibility to TG35-2-pseudotyped virus when introduced into nonpermissive cells but did not render these cells permissive to other FeLV subgroups or feline endogenous retrovirus. Moreover, human cells with genomic deletion of RFC were nonpermissive for TG35-2-pseudotyped virus infection, but the introduction of feline and human cDNAs rendered them permissive. Mutation analysis of FeLV Env demonstrated that amino acid substitutions within variable region A altered the specificity of the Env-receptor interaction. We isolated and reconstructed the full-length infectious TG35-2-phenotypic provirus from a naturally FeLV-infected cat, from which the FeLV Env (TG35-2) gene was previously isolated, and compared the replication of the virus in hematopoietic cell lines with that of FeLV-A 61E by measuring the viral RNA copy numbers. These results provide a tool for further investigation of FeLV infectious disease.IMPORTANCE Feline leukemia virus (FeLV) is a member of the genus Gammaretrovirus, which causes malignant diseases in cats. The most prevalent FeLV among cats is FeLV subgroup A (FeLV-A), and specific binding of FeLV-A Env to its viral receptor, thiamine transporter feTHTR1, is the first step of infection. In infected cats, novel variants of FeLV with altered receptor specificity for viral entry have emerged by mutation or recombination of the env gene. A novel FeLV variant arose from a subtle mutation of FeLV-A Env, which altered the specific interaction of the virus with its receptor. RFC, a folate transporter, is a potential receptor for the novel FeLV variant. The perturbation of specific retrovirus-receptor interactions under selective pressure by the host results in the emergence of novel viruses.Feline leukemia virus (FeLV) is horizontally transmitted among cats and causes a variety of hematopoietic disorders. Five subgroups of FeLV, A to D and T, each with distinct receptor usages, have been described. Recently, we identified a new FeLV Env (TG35-2) gene from a pseudotyped virus that does not belong to any known subgroup. FeLV-A is the primary virus from which other subgroups have emerged via mutation or recombination of the subgroup A env gene. Retrovirus entry into cells is mediated by the interaction of envelope protein (Env) with specific cell surface receptors. Here, phenotypic screening of a human/hamster radiation hybrid panel identified SLC19A1, a feline reduced folate carrier (RFC) and potential receptor for TG35-2-phenotypic virus. RFC is a multipass transmembrane protein. Feline and human RFC cDNAs conferred susceptibility to TG35-2-pseudotyped virus when introduced into nonpermissive cells but did not render these cells permissive to other FeLV subgroups or feline endogenous retrovirus. Moreover, human cells with genomic deletion of RFC were nonpermissive for TG35-2-pseudotyped virus infection, but the introduction of feline and human cDNAs rendered them permissive. Mutation analysis of FeLV Env demonstrated that amino acid substitutions within variable region A altered the specificity of the Env-receptor interaction. We isolated and reconstructed the full-length infectious TG35-2-phenotypic provirus from a naturally FeLV-infected cat, from which the FeLV Env (TG35-2) gene was previously isolated, and compared the replication of the virus in hematopoietic cell lines with that of FeLV-A 61E by measuring the viral RNA copy numbers. These results provide a tool for further investigation of FeLV infectious disease.IMPORTANCE Feline leukemia virus (FeLV) is a member of the genus Gammaretrovirus, which causes malignant diseases in cats. The most prevalent FeLV among cats is FeLV subgroup A (FeLV-A), and specific binding of FeLV-A Env to its viral receptor, thiamine transporter feTHTR1, is the first step of infection. In infected cats, novel variants of FeLV with altered receptor specificity for viral entry have emerged by mutation or recombination of the env gene. A novel FeLV variant arose from a subtle mutation of FeLV-A Env, which altered the specific interaction of the virus with its receptor. RFC, a folate transporter, is a potential receptor for the novel FeLV variant. The perturbation of specific retrovirus-receptor interactions under selective pressure by the host results in the emergence of novel viruses.
Author Kawasaki, Junna
Miyake, Ariko
Muto, Yutaro
Khan, Arshad H.
Ngo, Ha
Nishigaki, Kazuo
Smith, Desmond J.
Makundi, Isaac
Author_xml – sequence: 1
  givenname: Ariko
  surname: Miyake
  fullname: Miyake, Ariko
  organization: Laboratory of Molecular Immunology and Infectious Disease, Joint Faculty of Veterinary Medicine, Yamaguchi University, Yamaguchi, Japan
– sequence: 2
  givenname: Junna
  surname: Kawasaki
  fullname: Kawasaki, Junna
  organization: Laboratory of Molecular Immunology and Infectious Disease, Joint Faculty of Veterinary Medicine, Yamaguchi University, Yamaguchi, Japan
– sequence: 3
  givenname: Ha
  surname: Ngo
  fullname: Ngo, Ha
  organization: The United Graduate School of Veterinary Science, Yamaguchi University, Yamaguchi, Japan
– sequence: 4
  givenname: Isaac
  surname: Makundi
  fullname: Makundi, Isaac
  organization: The United Graduate School of Veterinary Science, Yamaguchi University, Yamaguchi, Japan
– sequence: 5
  givenname: Yutaro
  surname: Muto
  fullname: Muto, Yutaro
  organization: Laboratory of Molecular Immunology and Infectious Disease, Joint Faculty of Veterinary Medicine, Yamaguchi University, Yamaguchi, Japan
– sequence: 6
  givenname: Arshad H.
  surname: Khan
  fullname: Khan, Arshad H.
  organization: Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA
– sequence: 7
  givenname: Desmond J.
  surname: Smith
  fullname: Smith, Desmond J.
  organization: Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA
– sequence: 8
  givenname: Kazuo
  surname: Nishigaki
  fullname: Nishigaki, Kazuo
  organization: Laboratory of Molecular Immunology and Infectious Disease, Joint Faculty of Veterinary Medicine, Yamaguchi University, Yamaguchi, Japan, The United Graduate School of Veterinary Science, Yamaguchi University, Yamaguchi, Japan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30996094$$D View this record in MEDLINE/PubMed
BookMark eNptkctL7TAQxoMoenzs7vqSpQurSZq0jQtBDh4fHBR8HNyFaTrVXHuaY9IK_vfWJ15xMQzM_OabYb51stz6Fgn5w9ku56LYO5ud7jImMp1wvURGnOkiUYrLZTIayiJRaXG7RtZj_McYlzKTq2QtZVpnTMsRubrEqrdY0YlvoEM6hhAchn0KLT1qu_BML9HiovOB1kMAPfdP2NAJNq5FOsX-AecO6MyFPtIZBAdtt0lWamgibn3kDXIzOboenyTTi-PT8eE0sVKxLlEiE7KwFQihsSytLfO8wqzOOSotBWSgaw5al5UsFWqbV8ALUZWyFKKGXKUb5OBdd9GXc6wsDvdCYxbBzSE8Gw_O_N9p3b25808mUwXTeToIbH8IBP_YY-zM3EWLTQMt-j4aIThPRSFYPqB_v-_6WvL5yQHYeQds8DEGrL8QzsyrUWYwyrwZZbgecPEDt66DzvnXS13z-9ALpMKW1Q
CitedBy_id crossref_primary_10_1073_pnas_2114441119
crossref_primary_10_1128_jvi_01771_23
crossref_primary_10_1128_jvi_00229_22
crossref_primary_10_1128_JVI_02136_20
crossref_primary_10_1016_j_cvsm_2020_05_006
crossref_primary_10_3390_vetsci9090467
crossref_primary_10_1128_jvi_01400_23
Cites_doi 10.1038/tpj.2015.50
10.1073/pnas.1304704110
10.1038/sj.gt.3301206
10.1128/jvi.71.12.9823-9827.1997
10.1128/jvi.66.2.1219-1222.1992
10.1158/1078-0432.CCR-1066-03
10.1128/MMBR.00044-17
10.1002/ijc.2910210411
10.1128/jvi.67.6.3118-3125.1993
10.1128/jvi.52.2.695-698.1984
10.1007/s10555-007-9046-2
10.1093/oxfordjournals.molbev.a040454
10.1186/1471-2164-12-562
10.1016/j.jviromet.2005.06.017
10.1073/pnas.130200097
10.1128/jvi.65.8.4461-4469.1991
10.1016/j.virusres.2015.04.008
10.1128/JVI.75.22.10563-10572.2001
10.1128/jvi.58.3.825-834.1986
10.1128/jvi.66.3.1635-1640.1992
10.7554/eLife.22519
10.1128/JVI.00280-12
10.1007/BF02624087
10.1128/JVI.72.4.2686-2696.1998
10.1016/0042-6822(71)90266-2
10.1002/ijc.2910210314
10.1128/jvi.46.3.871-880.1983
10.1038/275656a0
10.1128/JVI.79.3.1351-1360.2005
10.1002/ijc.24050
10.1186/1742-4690-2-52
10.1016/j.mam.2012.07.006
10.1128/JVI.80.4.1619-1628.2006
10.1128/JVI.01385-13
10.1128/JVI.02317-08
10.1128/JVI.76.3.1527-1532.2002
10.1093/nar/gkh340
10.1101/gr.7.5.422
10.1534/genetics.114.167916
10.1016/0092-8674(89)90134-7
10.1128/jvi.49.2.629-632.1984
10.1126/science.287.5459.1828
10.1016/j.vetimm.2010.12.010
10.1073/pnas.1012344107
10.1128/JVI.80.6.3104-3107.2006
10.1016/0042-6822(92)90924-E
10.1128/JVI.73.8.6500-6505.1999
10.1128/jvi.62.3.722-731.1988
10.1128/JVI.03229-15
10.1073/pnas.89.18.8457
10.3390/v4112684
10.1182/blood.V95.3.1093.003k01_1093_1099
10.1093/molbev/msw054
10.1099/0022-1317-20-2-169
10.1128/JVI.01125-18
10.3390/v7010001
10.1371/journal.pone.0061009
10.1099/0022-1317-73-11-2839
10.1128/jvi.71.6.4531-4535.1997
10.1128/jvi.68.12.8296-8303.1994
10.1128/JVI.80.7.3378-3385.2006
10.1074/jbc.M607049200
10.3390/v10010029
10.1126/science.2893454
10.1111/j.1558-5646.1985.tb00420.x
10.1128/JVI.01267-13
10.1128/JVI.00716-16
10.1093/oxfordjournals.aje.a118408
10.1007/BF02618435
ContentType Journal Article
Copyright Copyright © 2019 American Society for Microbiology.
Copyright © 2019 American Society for Microbiology. 2019 American Society for Microbiology
Copyright_xml – notice: Copyright © 2019 American Society for Microbiology.
– notice: Copyright © 2019 American Society for Microbiology. 2019 American Society for Microbiology
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1128/JVI.00269-19
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
DocumentTitleAlternate Receptor for Novel FeLV Variant
EISSN 1098-5514
ExternalDocumentID PMC6580973
30996094
10_1128_JVI_00269_19
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NHGRI NIH HHS
  grantid: R21 HG007405
– fundername: ;
  grantid: R21 HG007405
– fundername: ;
  grantid: 15H04602
GroupedDBID ---
-~X
.55
.GJ
0R~
18M
29L
2WC
39C
3O-
4.4
41~
53G
5GY
5RE
5VS
6TJ
85S
AAFWJ
AAGFI
AAYJJ
AAYXX
ABPPZ
ACGFO
ACNCT
ADBBV
ADXHL
AENEX
AFFNX
AGVNZ
AI.
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BTFSW
C1A
CITATION
CS3
D0S
DIK
E3Z
EBS
EJD
F5P
FRP
GX1
H13
HYE
HZ~
IH2
KQ8
MVM
N9A
O9-
OHT
OK1
P2P
RHI
RNS
RPM
RSF
TR2
UPT
VH1
W2D
W8F
WH7
WOQ
X7M
Y6R
YQT
ZGI
ZXP
~02
~KM
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c450t-526248cda229ebbccb77de6f71e5942a6a9f1a99bd4b5e9c7da182db4b22fa753
ISSN 0022-538X
1098-5514
IngestDate Thu Aug 21 13:57:42 EDT 2025
Fri Jul 11 07:53:11 EDT 2025
Mon Jul 21 06:03:06 EDT 2025
Thu Apr 24 23:12:00 EDT 2025
Tue Jul 01 01:03:01 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 13
Keywords viral pathogenesis
viral envelope
cats
viral infection
endogenous retrovirus
viral receptor
feline leukemia virus
retroviruses
Language English
License Copyright © 2019 American Society for Microbiology.
All Rights Reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c450t-526248cda229ebbccb77de6f71e5942a6a9f1a99bd4b5e9c7da182db4b22fa753
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
A.M., J.K., and H.N. contributed equally to this work.
Citation Miyake A, Kawasaki J, Ngo H, Makundi I, Muto Y, Khan AH, Smith DJ, Nishigaki K. 2019. Reduced folate carrier: an entry receptor for a novel feline leukemia virus variant. J Virol 93:e00269-19. https://doi.org/10.1128/JVI.00269-19.
OpenAccessLink https://jvi.asm.org/content/jvi/93/13/e00269-19.full.pdf
PMID 30996094
PQID 2211328207
PQPubID 23479
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_6580973
proquest_miscellaneous_2211328207
pubmed_primary_30996094
crossref_primary_10_1128_JVI_00269_19
crossref_citationtrail_10_1128_JVI_00269_19
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2019-07-01
PublicationDateYYYYMMDD 2019-07-01
PublicationDate_xml – month: 07
  year: 2019
  text: 2019-07-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: 1752 N St., N.W., Washington, DC
PublicationTitle Journal of virology
PublicationTitleAlternate J Virol
PublicationYear 2019
Publisher American Society for Microbiology
Publisher_xml – name: American Society for Microbiology
References e_1_3_2_26_2
e_1_3_2_49_2
Hardy WD (e_1_3_2_22_2) 1976; 36
e_1_3_2_41_2
e_1_3_2_64_2
e_1_3_2_20_2
e_1_3_2_43_2
e_1_3_2_62_2
e_1_3_2_45_2
e_1_3_2_68_2
e_1_3_2_24_2
e_1_3_2_47_2
e_1_3_2_66_2
e_1_3_2_60_2
e_1_3_2_9_2
e_1_3_2_16_2
e_1_3_2_37_2
e_1_3_2_7_2
e_1_3_2_18_2
e_1_3_2_39_2
e_1_3_2_54_2
e_1_3_2_75_2
e_1_3_2_10_2
e_1_3_2_31_2
e_1_3_2_52_2
e_1_3_2_73_2
e_1_3_2_5_2
e_1_3_2_12_2
e_1_3_2_33_2
e_1_3_2_58_2
e_1_3_2_14_2
e_1_3_2_35_2
e_1_3_2_56_2
e_1_3_2_50_2
Hunter E (e_1_3_2_3_2) 1997
e_1_3_2_27_2
e_1_3_2_48_2
e_1_3_2_29_2
e_1_3_2_40_2
e_1_3_2_65_2
e_1_3_2_21_2
e_1_3_2_42_2
e_1_3_2_63_2
e_1_3_2_23_2
e_1_3_2_44_2
e_1_3_2_69_2
e_1_3_2_25_2
e_1_3_2_67_2
O'Hara B (e_1_3_2_28_2) 1990; 1
e_1_3_2_61_2
Rasheed S (e_1_3_2_46_2) 1980
e_1_3_2_15_2
e_1_3_2_38_2
e_1_3_2_8_2
e_1_3_2_17_2
e_1_3_2_59_2
e_1_3_2_6_2
e_1_3_2_19_2
Jones DT (e_1_3_2_71_2) 1992; 8
e_1_3_2_30_2
e_1_3_2_53_2
e_1_3_2_32_2
e_1_3_2_51_2
e_1_3_2_74_2
e_1_3_2_11_2
e_1_3_2_34_2
e_1_3_2_57_2
e_1_3_2_4_2
e_1_3_2_13_2
e_1_3_2_36_2
e_1_3_2_55_2
e_1_3_2_2_2
e_1_3_2_72_2
e_1_3_2_70_2
References_xml – ident: e_1_3_2_39_2
  doi: 10.1038/tpj.2015.50
– ident: e_1_3_2_61_2
  doi: 10.1073/pnas.1304704110
– ident: e_1_3_2_64_2
  doi: 10.1038/sj.gt.3301206
– ident: e_1_3_2_14_2
  doi: 10.1128/jvi.71.12.9823-9827.1997
– ident: e_1_3_2_30_2
  doi: 10.1128/jvi.66.2.1219-1222.1992
– ident: e_1_3_2_41_2
  doi: 10.1158/1078-0432.CCR-1066-03
– ident: e_1_3_2_2_2
  doi: 10.1128/MMBR.00044-17
– ident: e_1_3_2_23_2
  doi: 10.1002/ijc.2910210411
– ident: e_1_3_2_12_2
  doi: 10.1128/jvi.67.6.3118-3125.1993
– ident: e_1_3_2_63_2
  doi: 10.1128/jvi.52.2.695-698.1984
– ident: e_1_3_2_52_2
  doi: 10.1007/s10555-007-9046-2
– ident: e_1_3_2_70_2
  doi: 10.1093/oxfordjournals.molbev.a040454
– ident: e_1_3_2_38_2
  doi: 10.1186/1471-2164-12-562
– volume: 36
  start-page: 582
  year: 1976
  ident: e_1_3_2_22_2
  article-title: Biology of feline leukemia virus in the natural environment
  publication-title: Cancer Res
– ident: e_1_3_2_74_2
  doi: 10.1016/j.jviromet.2005.06.017
– ident: e_1_3_2_36_2
  doi: 10.1073/pnas.130200097
– ident: e_1_3_2_21_2
  doi: 10.1128/jvi.65.8.4461-4469.1991
– ident: e_1_3_2_51_2
  doi: 10.1016/j.virusres.2015.04.008
– ident: e_1_3_2_31_2
  doi: 10.1128/JVI.75.22.10563-10572.2001
– ident: e_1_3_2_43_2
  doi: 10.1128/jvi.58.3.825-834.1986
– ident: e_1_3_2_29_2
  doi: 10.1128/jvi.66.3.1635-1640.1992
– ident: e_1_3_2_54_2
  doi: 10.7554/eLife.22519
– ident: e_1_3_2_18_2
  doi: 10.1128/JVI.00280-12
– ident: e_1_3_2_47_2
  doi: 10.1007/BF02624087
– ident: e_1_3_2_20_2
  doi: 10.1128/JVI.72.4.2686-2696.1998
– ident: e_1_3_2_16_2
  doi: 10.1016/0042-6822(71)90266-2
– ident: e_1_3_2_24_2
  doi: 10.1002/ijc.2910210314
– ident: e_1_3_2_25_2
  doi: 10.1128/jvi.46.3.871-880.1983
– ident: e_1_3_2_48_2
  doi: 10.1038/275656a0
– ident: e_1_3_2_15_2
  doi: 10.1128/JVI.79.3.1351-1360.2005
– ident: e_1_3_2_8_2
  doi: 10.1002/ijc.24050
– ident: e_1_3_2_4_2
  doi: 10.1186/1742-4690-2-52
– ident: e_1_3_2_44_2
  doi: 10.1016/j.mam.2012.07.006
– ident: e_1_3_2_60_2
  doi: 10.1128/JVI.80.4.1619-1628.2006
– ident: e_1_3_2_62_2
  doi: 10.1128/JVI.01385-13
– ident: e_1_3_2_34_2
  doi: 10.1128/JVI.02317-08
– ident: e_1_3_2_42_2
  doi: 10.1128/JVI.76.3.1527-1532.2002
– ident: e_1_3_2_69_2
  doi: 10.1093/nar/gkh340
– ident: e_1_3_2_37_2
  doi: 10.1101/gr.7.5.422
– ident: e_1_3_2_40_2
  doi: 10.1534/genetics.114.167916
– ident: e_1_3_2_55_2
  doi: 10.1016/0092-8674(89)90134-7
– ident: e_1_3_2_66_2
  doi: 10.1128/jvi.49.2.629-632.1984
– ident: e_1_3_2_35_2
  doi: 10.1126/science.287.5459.1828
– ident: e_1_3_2_49_2
  doi: 10.1016/j.vetimm.2010.12.010
– ident: e_1_3_2_53_2
  doi: 10.1073/pnas.1012344107
– ident: e_1_3_2_58_2
  doi: 10.1128/JVI.80.6.3104-3107.2006
– start-page: 393
  volume-title: Proceedings of the third international feline leukemia virus meeting
  year: 1980
  ident: e_1_3_2_46_2
– ident: e_1_3_2_26_2
  doi: 10.1016/0042-6822(92)90924-E
– ident: e_1_3_2_32_2
  doi: 10.1128/JVI.73.8.6500-6505.1999
– ident: e_1_3_2_50_2
  doi: 10.1128/jvi.62.3.722-731.1988
– ident: e_1_3_2_19_2
  doi: 10.1128/JVI.03229-15
– start-page: 71
  volume-title: Retroviruses
  year: 1997
  ident: e_1_3_2_3_2
– ident: e_1_3_2_10_2
  doi: 10.1073/pnas.89.18.8457
– ident: e_1_3_2_7_2
  doi: 10.3390/v4112684
– ident: e_1_3_2_33_2
  doi: 10.1182/blood.V95.3.1093.003k01_1093_1099
– volume: 1
  start-page: 119
  year: 1990
  ident: e_1_3_2_28_2
  article-title: Characterization of a human gene conferring sensitivity to infection by gibbon ape leukemia virus
  publication-title: Cell Growth Differ
– ident: e_1_3_2_68_2
  doi: 10.1093/molbev/msw054
– volume: 8
  start-page: 275
  year: 1992
  ident: e_1_3_2_71_2
  article-title: The rapid generation of mutation data matrices from protein sequences
  publication-title: Comput Appl Biosci
– ident: e_1_3_2_17_2
  doi: 10.1099/0022-1317-20-2-169
– ident: e_1_3_2_57_2
  doi: 10.1128/JVI.01125-18
– ident: e_1_3_2_56_2
  doi: 10.3390/v7010001
– ident: e_1_3_2_6_2
  doi: 10.1371/journal.pone.0061009
– ident: e_1_3_2_11_2
  doi: 10.1099/0022-1317-73-11-2839
– ident: e_1_3_2_59_2
  doi: 10.1128/jvi.71.6.4531-4535.1997
– ident: e_1_3_2_13_2
  doi: 10.1128/jvi.68.12.8296-8303.1994
– ident: e_1_3_2_27_2
  doi: 10.1128/JVI.80.7.3378-3385.2006
– ident: e_1_3_2_75_2
  doi: 10.1074/jbc.M607049200
– ident: e_1_3_2_5_2
  doi: 10.3390/v10010029
– ident: e_1_3_2_9_2
  doi: 10.1126/science.2893454
– ident: e_1_3_2_72_2
  doi: 10.1111/j.1558-5646.1985.tb00420.x
– ident: e_1_3_2_67_2
  doi: 10.1128/JVI.01267-13
– ident: e_1_3_2_65_2
  doi: 10.1128/JVI.00716-16
– ident: e_1_3_2_73_2
  doi: 10.1093/oxfordjournals.aje.a118408
– ident: e_1_3_2_45_2
  doi: 10.1007/BF02618435
SSID ssj0014464
Score 2.3665657
Snippet Feline leukemia virus (FeLV) is a member of the genus Gammaretrovirus , which causes malignant diseases in cats. The most prevalent FeLV among cats is FeLV...
Feline leukemia virus (FeLV) is horizontally transmitted among cats and causes a variety of hematopoietic disorders. Five subgroups of FeLV, A to D and T, each...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
SubjectTerms Amino Acid Sequence
Animals
Cats
Cell Line
Cricetinae
Endogenous Retroviruses - metabolism
Gene Products, env - genetics
Genes, env - genetics
HeLa Cells
Humans
Leukemia Virus, Feline - genetics
Leukemia Virus, Feline - metabolism
Leukemia, Feline - virology
Phylogeny
Proviruses
Receptors, Virus - genetics
Receptors, Virus - metabolism
Reduced Folate Carrier Protein - classification
Reduced Folate Carrier Protein - genetics
Reduced Folate Carrier Protein - metabolism
RNA, Viral - genetics
Sequence Alignment
Viral Envelope Proteins - genetics
Virus Internalization
Virus Replication
Virus-Cell Interactions
Title Reduced Folate Carrier: an Entry Receptor for a Novel Feline Leukemia Virus Variant
URI https://www.ncbi.nlm.nih.gov/pubmed/30996094
https://www.proquest.com/docview/2211328207
https://pubmed.ncbi.nlm.nih.gov/PMC6580973
Volume 93
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfKEGgviG_Kl4wET1GgcRyn4W2aVnUVrRBs1d4ix3FG1C2t-gEaD_zt3Nlxlo4hwV6iKnWTyr9fLndn3-8Ieas1vNaCfu4HMmI-F3ngZznHdJgoRCy4CoxuwXgihsd8dBKddDq_2tUl6-y9-nltXclNUIVzgCtWyf4Hss1F4QR8BnzhCAjD8Z8w_oK6q-AxDiA-XWvcvIH950z9cuUdYMsQdAv1AuJqu1vSm8y_6zNvoI1z-UlvZvq8lN60XG5W3hTCZllt5epb7irWw7Uz8OPyQtqNPXvLcjZvDLf8IVfS9sIegXPcWP3JqUnKDpsTYznbVLkZeLiSUrXzD6bkaWsvh1tYau8yHZeXKlJt64uBb2haCcO7xxpc1DNFr61tkW3PRMe88HpLz7B6YTQ9xJSYSHxreFugL84N6mEP9WdsI-Urytqfx_tAVNQrukVuMwgzmMv21KtQECpzpzaP_9sVTrD-h_aNd8ldd5dt7-aPkOXqztuWK3N0n9yrQaV7llAPSEdXD8kd25X04hH5WtOKWlrRmlYfqayoIRV1pKKAApXUkIpaUlFHKmpIRWtSPSbHg4Oj_aFf997wFY96az9igvG-yiVjic4ypbI4zrUo4kBHCWdSyKQIZJLAg51FOlFxLiFSzTOeMVZIiIGfkJ1qXulnhBasFwuVhAkXmmPRnIwiplGkNIyUyIsu8dycpaoWpsf-KGepCVBZP4XJTs1kp0HSJe-a0QsryPKXcW_c9KdgMXEZTFZ6vlmljAVByMDzjbvkqYWjuZLDsUviLaCaAajGvv1NVX4zquw1lZ7f-JcvyO7l8_WS7KyXG_0KPN519trQ8jer_KyI
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Reduced+Folate+Carrier%3A+an+Entry+Receptor+for+a+Novel+Feline+Leukemia+Virus+Variant&rft.jtitle=Journal+of+virology&rft.au=Miyake%2C+Ariko&rft.au=Kawasaki%2C+Junna&rft.au=Ngo%2C+Ha&rft.au=Makundi%2C+Isaac&rft.date=2019-07-01&rft.pub=American+Society+for+Microbiology&rft.issn=0022-538X&rft.eissn=1098-5514&rft.volume=93&rft.issue=13&rft_id=info:doi/10.1128%2FJVI.00269-19&rft_id=info%3Apmid%2F30996094&rft.externalDocID=PMC6580973
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-538X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-538X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-538X&client=summon